A new COVID-19 test approved by FDA doesn't need a laboratory and can deliver results in just 5 minutes

There’s a new COVID-19 test from healthcare technology manufacturer Abbott that looks to be the best yet in terms of results. This latest coronavirus test that triggers the current global pandemic has been granted emergency clearance for use by the U.S. Food and Drug Administration, and will start production next week, beginning next week with a potential performance of 50,000 per day.

Unlike the rapid tests that have been used in other countries, and that received a new type of authorization under an FDA guideline that doesn’t confirm the accuracy of the results, this rapid testing solution uses the molecular testing method, which works with saliva and mucus samples swabbed from a patient.

This means that it works by detecting a portion of the virus 'RNA in a patient, which means that it is much easier to detect the virus’ actual existence during infection, whereas other tests that scan the blood for antibodies used in point-of-care settings will only detect antibodies that may be present in recovered patients that do not have the virus actively.

In total, Abbott now says that it believes it will produce 5 million tests in April, split between these new rapid tests and the lab tests that it received emergency use authorization for by the FDA on March 18. Read More in the source